1. Home
  2. MBINM vs BRTX Comparison

MBINM vs BRTX Comparison

Compare MBINM & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBINM
  • BRTX
  • Stock Information
  • Founded
  • MBINM N/A
  • BRTX 1997
  • Country
  • MBINM United States
  • BRTX United States
  • Employees
  • MBINM 618
  • BRTX N/A
  • Industry
  • MBINM Major Banks
  • BRTX Managed Health Care
  • Sector
  • MBINM Finance
  • BRTX Health Care
  • Exchange
  • MBINM Nasdaq
  • BRTX Nasdaq
  • Market Cap
  • MBINM N/A
  • BRTX 11.3M
  • IPO Year
  • MBINM N/A
  • BRTX N/A
  • Fundamental
  • Price
  • MBINM $25.92
  • BRTX $1.55
  • Analyst Decision
  • MBINM
  • BRTX Strong Buy
  • Analyst Count
  • MBINM 0
  • BRTX 1
  • Target Price
  • MBINM N/A
  • BRTX $18.00
  • AVG Volume (30 Days)
  • MBINM N/A
  • BRTX 101.9K
  • Earning Date
  • MBINM N/A
  • BRTX 11-12-2024
  • Dividend Yield
  • MBINM N/A
  • BRTX N/A
  • EPS Growth
  • MBINM N/A
  • BRTX N/A
  • EPS
  • MBINM N/A
  • BRTX N/A
  • Revenue
  • MBINM N/A
  • BRTX $377,000.00
  • Revenue This Year
  • MBINM N/A
  • BRTX $482.76
  • Revenue Next Year
  • MBINM N/A
  • BRTX $212.24
  • P/E Ratio
  • MBINM N/A
  • BRTX N/A
  • Revenue Growth
  • MBINM N/A
  • BRTX 189.55
  • 52 Week Low
  • MBINM N/A
  • BRTX $1.03
  • 52 Week High
  • MBINM N/A
  • BRTX $3.67
  • Technical
  • Relative Strength Index (RSI)
  • MBINM 45.91
  • BRTX 54.98
  • Support Level
  • MBINM $25.55
  • BRTX $1.40
  • Resistance Level
  • MBINM $26.92
  • BRTX $1.60
  • Average True Range (ATR)
  • MBINM 0.24
  • BRTX 0.10
  • MACD
  • MBINM -0.07
  • BRTX 0.01
  • Stochastic Oscillator
  • MBINM 27.01
  • BRTX 85.29

About MBINM Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and Banking segment that provides a wide range of financial products and services to consumers and businesses, including commercial and other consumer loan products.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: